These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 9848508

  • 21. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
    Kennedy AR, Beazer-Barclay Y, Kinzler KW, Newberne PM.
    Cancer Res; 1996 Feb 15; 56(4):679-82. PubMed ID: 8630994
    [Abstract] [Full Text] [Related]

  • 22. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
    Maki PA, Paterson Y, Kennedy AR.
    Nutr Cancer; 1994 Feb 15; 22(2):185-93. PubMed ID: 14502847
    [Abstract] [Full Text] [Related]

  • 23. Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.
    Kennedy AR, Kritchevsky D, Shen WC.
    Pharm Res; 2003 Dec 15; 20(12):1908-10. PubMed ID: 14725352
    [Abstract] [Full Text] [Related]

  • 24. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.
    St Clair WH, Billings PC, Carew JA, Keller-McGandy C, Newberne P, Kennedy AR.
    Cancer Res; 1990 Feb 01; 50(3):580-6. PubMed ID: 2297699
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.
    Armstrong WB, Taylor TH, Kennedy AR, Melrose RJ, Messadi DV, Gu M, Le AD, Perloff M, Civantos F, Goodwin WJ, Wirth LJ, Kerr AR, Meyskens FL.
    Cancer Prev Res (Phila); 2013 May 01; 6(5):410-8. PubMed ID: 23639862
    [Abstract] [Full Text] [Related]

  • 28. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
    Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Meyskens FL.
    Laryngoscope; 2003 Oct 01; 113(10):1687-702. PubMed ID: 14520092
    [Abstract] [Full Text] [Related]

  • 29. Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.
    Clemente A, Arques Mdel C.
    World J Gastroenterol; 2014 Aug 14; 20(30):10305-15. PubMed ID: 25132747
    [Abstract] [Full Text] [Related]

  • 30. Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells.
    Billings PC, Brandon DL, Habres JM.
    Eur J Cancer; 1991 Aug 14; 27(7):903-8. PubMed ID: 1834126
    [Abstract] [Full Text] [Related]

  • 31. Development of tobacco smoke-induced lung tumors in mice fed Bowman-Birk protease inhibitor concentrate (BBIC).
    Witschi H, Espiritu I.
    Cancer Lett; 2002 Sep 26; 183(2):141-6. PubMed ID: 12065088
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Distribution of the Bowman Birk protease inhibitor in mice following oral administration.
    Billings PC, St Clair WH, Maki PA, Kennedy AR.
    Cancer Lett; 1992 Mar 15; 62(3):191-7. PubMed ID: 1596863
    [Abstract] [Full Text] [Related]

  • 34. Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable.
    Hsieh CC, Hernández-Ledesma B, Jeong HJ, Park JH, de Lumen BO.
    PLoS One; 2010 Jan 26; 5(1):e8890. PubMed ID: 20126654
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Polylysine conjugates of Bowman-Birk protease inhibitor as targeted anti-carcinogenic agents.
    Persiani S, Yeung A, Shen WC, Kennedy AR.
    Carcinogenesis; 1991 Jun 26; 12(6):1149-52. PubMed ID: 2044199
    [Abstract] [Full Text] [Related]

  • 38. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family.
    Clementea A, Domoney C.
    Curr Protein Pept Sci; 2006 Jun 26; 7(3):201-16. PubMed ID: 16787260
    [Abstract] [Full Text] [Related]

  • 39. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29.
    Fereidunian A, Sadeghalvad M, Oscoie MO, Mostafaie A.
    Arch Med Res; 2014 Aug 26; 45(6):455-61. PubMed ID: 25014623
    [Abstract] [Full Text] [Related]

  • 40. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H, Kennedy AR, Witschi H, Shen WC.
    J Drug Target; 1993 Aug 26; 1(1):41-9. PubMed ID: 8069543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.